Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $10.4 million.

  • Inspire Medical Systems' Prepaid Assets fell 1387.28% to $10.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.4 million, marking a year-over-year decrease of 1387.28%. This contributed to the annual value of $10.4 million for FY2025, which is 1387.28% down from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Prepaid Assets is $10.4 million, which was down 1387.28% from $14.1 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Prepaid Assets registered a high of $28.8 million during Q2 2024, and its lowest value of $1.6 million during Q1 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $8.2 million (2023), whereas its average is $8.6 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 23108.81% in 2024, then tumbled by 5488.09% in 2025.
  • Inspire Medical Systems' Prepaid Assets (Quarter) stood at $2.7 million in 2021, then surged by 106.95% to $5.5 million in 2022, then surged by 74.3% to $9.6 million in 2023, then increased by 25.84% to $12.1 million in 2024, then dropped by 13.87% to $10.4 million in 2025.
  • Its Prepaid Assets stands at $10.4 million for Q4 2025, versus $14.1 million for Q3 2025 and $13.0 million for Q2 2025.